PUBLISH WITH UGC VALID ISBN

  • Saturday,Apr,20th,2024
  • editor@sarapublication.com
  • +91 88 66 00 3636
  • +91 88 66 11 3636

MEDICAL SCIENCE

Understanding The Omicron Variant Of Coronavirus: Outbreak And Impacts On Academic Research

300

by Dr. Prithiviraj Nagarajan

ISBN Number : 978 - 93 - 91478 - 10 - 0


Authors Details

Author Name Image About Author
Dr. Prithiviraj Nagarajan
Assistant Professor (Research), Multi-Disciplinary Centre for Biomedical Research, Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Kirumampakkam, Puducherry-607403, India.
Dr. Anusheela Howlader
Assistant Professor, Department of Microbiology, Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Kirumampakkam, Puducherry-607403, India
Dr. Leena Rajathy Port Louis
Animal Welfare Ofcer, Department of Pharmacology Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Kirumampakkam, Puducherry-607403, India.
Dr. G. Subashchandrabose
Lecturer in Statistics, Community Medicine, Aarupadai Veedu Medical College & Hospital, Vinayaka Mission's Research Foundation (Deemed to be University), Kirumampakkam, Puducherry-607403, India

Book Description

Early 2022 saw an outbreak of the coronavirus SARS-CoV-2 variant known as Omicron, which has become more contagious than the previous VOC alpha, beta, and gamma variants, and it shares many mutations. Still, so far, Omicron transmission has exceeded many borders worldwide compared to other kinds of SARS-CoV-2; there has been a signicant increase in the number of conrmed cases globally, and it is re-emerging currently in India. The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the Ministry of Health and Family Welfare (MoHFW), and other research institutions, as well as worldwide international press media, provided data on “Omicron” outbreaks in India. Our chapter recorded information about the prevalence and clinical characteristics of the Omicron variant of SARSCoV- 2 from November 24th, 2021, to January 17th, 2022. Our highlights will talk about its global transmission, characteristics, and impact on vaccine efciency, and possible strategies to prevent and overcome the spread of the Omicron variant.


NEW RELEASES